Breast Cancer Patients May Benefit from Second Opinion
ABSTRACT: Emesis as an adverse event of antineoplastic therapy can be troublesome for many oncology patients.
In the United States, kidney cancer (renal cell carcinoma) is estimated to be the seventh most common cancerous condition diagnosed in men and the 13th most common in women, accounting for 2.7% of all malignant conditions.